MD Director Transfers 54,646 Shares to Living Trust — Form 4

Rhea-AI Filing Summary

Pediatrix Medical Group insider transfer disclosure. Thomas McEachin, a director, reported transfers of common stock on August 19 and August 20, 2025. The filings show 54,021 shares were transferred on August 19, 2025, and 625 shares on August 20, 2025, each reported as dispositions at $0. After the transactions the report lists 11,427 shares held directly and 54,646 shares held indirectly by the Thomas A. McEachin Living Trust dated April 17, 2025. The Form 4 was executed by an attorney-in-fact and signed on August 21, 2025. The reporting person and spouse are identified as trustees and beneficiaries of the trust that holds the reported securities.

Positive

• Disclosed transfers of 54,021 and 625 shares into the Thomas A. McEachin Living Trust
• Form 4 filed and signed with explanatory footnotes detailing trusteeship and beneficiary status

Negative

• None.

Insights

Financial Analyst

TL;DR: Director transferred substantial shares into a family trust; disclosure updates direct and indirect holdings.

The Form 4 shows two non-derivative dispositions totaling 54,646 shares moved from direct ownership into an entity identified as the Thomas A. McEachin Living Trust. Reported prices are $0 indicating transfers to an affiliated trust rather than open-market sales. The filing updates beneficial ownership: direct holdings are listed as 11,427 shares and indirect holdings via trust as 54,646. For investors, this is a governance/ownership disclosure without reported cash proceeds or option activity; its materiality is primarily around ownership structure rather than company operating performance.

Corporate Governance Expert

TL;DR: Transfers documented to a living trust with the reporting person and spouse as trustees/beneficiaries; Form 4 properly filed and signed.

The document explicitly states the reporting person and spouse serve as trustees and beneficiaries of the trust receiving the shares. Two separate transfer events are dated August 19 and August 20, 2025, and the Form 4 includes an explanatory footnote confirming trust ownership. The signature block shows an attorney-in-fact executed the filing on August 21, 2025. This is a routine ownership reclassification disclosed under Section 16 rules rather than an operational disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McEachin Thomas

(Last) (First) (Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE FL 33323

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		G		54,021(1)	D	$0	12,052	D
Common Stock	08/20/2025		G		625(2)	D	$0	11,427	D
Common Stock								54,646	I	Thomas A. McEachin Living Trust dated April 17, 2025(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 19, 2025, the reporting person transferred 54,021 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.

2. On August 20, 2025, the reporting person transferred 625 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.

3. Footnote for Form 4: The reporting person and his spouse are trustees and beneficiaries of the trust that holds the reported securities.

	/s/ Mary Ann E. Moore, Attorney-in-Fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Thomas McEachin transfer according to the Form 4 for MD?

The Form 4 reports transfers of 54,021 shares on 08/19/2025 and 625 shares on 08/20/2025.

How many shares does the filing list as indirectly owned after the transfers?

The filing lists 54,646 shares as indirectly owned by the Thomas A. McEachin Living Trust dated April 17, 2025.

What direct holdings are reported after the transactions?

Following the reported dispositions, the Form 4 shows 11,427 shares held directly by the reporting person.

Who is listed as trustees or beneficiaries of the trust that received the shares?

The filing states the reporting person and his spouse are trustees and beneficiaries of the trust holding the reported securities.

When was the Form 4 signed and by whom?

The Form 4 bears a signature by Mary Ann E. Moore, Attorney-in-Fact dated 08/21/2025.